Condition

Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type clinical trials that are recruiting, in China. By phase: Phase 2 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type clinical trials

StudyPhaseWhereStatusRegistered
Combining sintilimab with chemotherapy for advanced NK/T-cell lymphoma Phase 2 Guangzhou, Guangdong Recruiting Sep 3, 2024
Combination treatment for advanced NK/T-cell lymphoma Phase 1/2 Beijing, Beijing Municipality Recruiting Apr 19, 2024
Combining chemotherapy and radiation for early-stage NK/T-cell lymphoma treatment Phase 2 Fuzhou, Fujian and 6 other locations Recruiting Mar 18, 2024

All recruiting trials (3)

Related topics

T-lymphoblastic LymphomaCamrelizumabSintilimab

Quick answers

How many Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.